Condition
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) clinical trials that are recruiting, at sites in 4 countries (most in Italy (1), Netherlands (1), Austria (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Rapid guideline-based therapy after a heart attack | — | Heerlen, Limburg | Recruiting | Aug 19, 2026 |
| Drug-coated balloon treatment during emergency angioplasty for STEMI | — | Vienna | Recruiting | Feb 27, 2026 |
| AI detection of hidden coronary occlusions and timing of treatment for heart attacks | — | Bolzano, BZ | Recruiting | Apr 4, 2025 |
| Evaluating Vicagrel for patients with Acute Coronary Syndrome undergoing heart procedures | Phase 3 | Shenyang, Liaoning | Recruiting | Aug 29, 2024 |
All recruiting trials (4)
-
Rapid guideline-based therapy after a heart attack
This project tests whether starting guideline-driven secondary prevention soon after a heart attack helps people who had PCI reach better risk-factor control and fewer heart events.
-
Drug-coated balloon treatment during emergency angioplasty for STEMI
This registry will try using drug-coated balloons instead of stents during emergency PCI for people with ST-elevation heart attacks to see how the procedure and patient outcomes compare.
-
AI detection of hidden coronary occlusions and timing of treatment for heart attacks
This project tests whether an AI reading of 12‑lead ECGs can find hidden coronary occlusions in adults with suspected non‑ST‑elevation ACS and whether the time to PCI after that detection relates to troponin peak levels.
-
Evaluating Vicagrel for patients with Acute Coronary Syndrome undergoing heart procedures
This study is testing if a new medication called Vicagrel can help people with Acute Coronary Syndrome who are having heart procedures feel better and stay safe compared to a standard treatment.
Related topics
Quick answers
How many Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Italy (1 trial), Netherlands (1 trial), Austria (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.